Combination of | |
---|---|
Glucose | Monosaccharide |
Fructose | Monosaccharide |
Phosphoric acid | Acid |
Clinical data | |
Trade names | Emetrol |
AHFS/Drugs.com | Consumer Drug Information |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
Glucose/fructose/phosphoric acid (trade name Emetrol) is an over-the-counter antiemetic taken to relieve nausea and vomiting. Made by WellSpring Pharmaceutical Corporation, it was formerly distributed by McNeil Consumer Healthcare.
History
Emetrol was created by Kinney and Company of Columbus, Indiana and was first used in 1949.
It is a phosphorated carbohydrate solution, and comes in syrup form.
Contraindications
Since Emetrol contains fructose it is contraindicated for people with hereditary fructose intolerance (HFI). In diabetes patients, it can cause potentially harmful hyperglycaemia (high blood sugar).
References
- "History of Emetrol, a Classic American Remedy for Nausea". Archived from the original on 2011-03-05.
- Consumer Drug Information
External links
This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |